Global consulting and market access

Work with industry-recognized experts who apply scientific methodologies to conduct the full scope of health economics and outcomes research for effective strategic planning. We combine rigorous, technical expertise with an understanding of local markets and multiple disease states to deliver relevant, transparent, and credible results to help inform practical strategies and tactics that communicate a robust portfolio of value-based evidence.

When launching products outside the U.S., we provide deep understanding of the environment, competition, and considerations for market access across Europe and HTA countries. We evaluate how your product many be viewed by payers and assess what may be needed beyond your clinical trials. 

With strategic global data partnerships in the US, Germany, the UK, the Netherlands, France, Sweden, Canada, Japan, and China, we support our clients' global strategies along the entire product lifecycle.

Our databases are sourced from administrative claims, electronic medical records, or disease registries, and capture patient-level health information and outcomes for healthcare services performed in various care settings.

Our global team offers the full range of regulatory services needed to enter and operate in international markets. Our strong foundation of technical, regulatory, and scientific expertise, makes us uniquely positioned to support pharmaceutical operations worldwide.

Along the whole product lifecycle from discovery through launch, our international team provides true end-to-end solutions for pharmacovigilance system & operation as well as benefit-risk-management services. Our global footprint enables us to cover all needs worldwide, on local affiliate level as well as for the global & headquarter functions.

From innovation to commercialization, our global teams provide strategy consultancy on all things that impact the quality and compliance of the final product.